Steroids 36: Synthesis of 16,16-dimethyl-17-ketosteroids and 16,16-dimethyl-17β-hydroxysteroids
作者:Janos Wolfling、Gyula Schneider、Gyorgy Dombi
DOI:10.1016/0039-128x(88)90022-0
日期:1988.3
Direct conversion of 17-ketosteroids (Ia-f) into 16,16-dimethyl-17 beta-hydroxysteroids (IIa-f) and 16,16-dimethyl-17-ketosteroids (IIIa-f) was achieved with methyl iodide in the presence of NaH.
WOLFLING, JANOS;SCHNEIDER, GYULA;DOMBI, GYORGY, STEROIDS, 51,(1988) N-4, C. 329-335
作者:WOLFLING, JANOS、SCHNEIDER, GYULA、DOMBI, GYORGY
DOI:——
日期:——
INHIBITORS OF TYPE 3 3ALPHA-HYDROXYSTEROID DEHYDROGENASE
申请人:Endorecherche Inc.
公开号:EP1102582A2
公开(公告)日:2001-05-30
[EN] INHIBITION OF TYPE 3 3 alpha -HYDROXYSTEROID DEHYDROGENASE<br/>[FR] INHIBITION DE LA 3 DOLLAR G(a)-HYDROXYSTEROID-DESHYDROGENASE DE TYPE 3
申请人:ENDORECHERCHE INC
公开号:WO2000007576A2
公开(公告)日:2000-02-17
Novel methods of treating and/or inhibiting development of prostatic cancer, benign prostatic hyperplasia, prostatitis, acne, seborrhea, hirsutism or androgenic alopecia utilize inhibitors of type 3 3α-hydroxysteroid dehydrogenase alone or in combination with other active pharmaceuticals such as inhibitors of type 5 17β-hydroxysteroid dehydrogenase. Novel inhibitors and pharmaceutical products are also disclosed.